Companies›Healthcare›Healthcare›Healthcare Services

GlobalSpace Technologies Limit

Healthcare › Healthcare Services
₹36.90
at close · 8 Oct 2026
▲ 2.24 (+6.46%)
ThemesArtificial Intelligence· growing

Latest filings

  1. AGM approves re-appointment of Independent Director and Managing Director · Management Changes
  2. AGM results: all 6 resolutions passed with strong majority · Compliance
  3. GlobalSpace Technologies 16th AGM: all 6 resolutions passed · Board & Shareholder Meetings
All filings ↓
Ask Nexa about GlobalSpace Technologies Limit

Snapshot

What the business is, and whether it's a good one at a fair price.

A Healthcare Services company listed on BSE, reporting revenue of ₹51 Cr over the trailing twelve months.

Market Cap
₹119 Cr
P / E (TTM)
38.9×
EV / EBITDA
26.0×
Div Yield
—
Growth
13.7%▲
Revenue 5y CAGR
PAT -12.9% · EBITDA -14.4%
Quality
5.0%·
ROCE (FY26)
ROE 5.0% · margin 9.1%
Leverage
0.06·
Debt / Equity · low
Net debt ₹3.14 Cr
Revenue FY19→FY26
3.4×▲
Revenue change
₹15 Cr → ₹51 Cr
Cash conversion
-3.40×▼
Operating cash ÷ profit · 4 yrs
₹-2.35 L Cr on ₹69,103 Cr
Moves on a normal day
2.21%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 70 Healthcare Services peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#34/63
P/B#18/57
ROCE#47/69
ROE#39/57
Debt / Equity#23/56
EBITDA margin#47/57
Revenue growth#6/57
Profit growth#1/55

Scorecard

Measured from the filed financials, judged against its Healthcare Services peers · as of FY26 — not investment advice

Strengths
Revenue compounding 14% a year over 5 years
Debt at 0.06× equity
lower than 60% of its 56 Healthcare Services peers
Concerns
Profit shrinking over 5 years (−13% a year)
Over 4 years it reported ₹69,103 Cr of profit and an operating cash outflow of ₹2.35 L Cr — -3.40×
Less than 60p of every ₹1 of profit arrived as cash

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from GlobalSpace Technologies Limit's filed financials and exchange disclosures

What does GlobalSpace Technologies Limit do?

GlobalSpace Technologies Limit is a Healthcare Services company listed on BSE.

Is GlobalSpace Technologies Limit profitable?

Yes. Over the trailing twelve months GlobalSpace Technologies Limit reported a net profit of ₹2.85 Cr on revenue of ₹51 Cr.

Does GlobalSpace Technologies Limit pay a dividend?

Not in the latest reported year — GlobalSpace Technologies Limit's dividend payout for FY26 was nil.

Is GlobalSpace Technologies Limit debt-free?

No. It reported borrowings of ₹3.29 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹3.14 Cr after cash. Debt stands at 0.06× equity. That is lower than 60% of its 56 Healthcare Services peers.

Is GlobalSpace Technologies Limit expensive compared with its peers?

On trailing P/E, GlobalSpace Technologies Limit ranks 34 of 63 in Healthcare Services — cheaper than 47% of them, against an industry median of 37.2×. This is a position, not a valuation judgement.

How much does the GlobalSpace Technologies Limit share price move in a day?

On a typical session GlobalSpace Technologies Limit moves 2.21% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track GlobalSpace Technologies Limit's announcements?

Every NSE and BSE filing by GlobalSpace Technologies Limit appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.